We are providing electronically activated purification of biomolecules for biopharmaceutical and protein production. By utilizing our patent-pending invention, we build functionalized polymer surfaces that can with high specificity and high capacity capture and release biomolecules at the press of a button. Making today's complex biopharmaceutical and protein manufacturing simpler, more effective, and digital.
| Website | http://nycteatechnologies.com |
| Employees | 11 (6 on RocketReach) |
| Founded | 2020 |
| Technologies |
HTML
,
Twitter
,
Microsoft Outlook
+2 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Biotechnology, Bioprocessing, Pharmaceutical Technology, Drug Development, Protein Production, Biopharmaceutical Manufacturing, Polymer Technology, Downstream Processing, Surface Modification, Chromatography, Purification Technology, Pharmaceutical Purification |
| Competitors | Amazon, Microsoft, IBM, Google, Salesforce, Palantir Technologies, DataRobot, Dataiku, C3 AI, H2O.ai +41 more (view full list) |
Looking for a particular Nyctea Technologies employee's phone or email?
Gustav Ferrand-Drake is the Co-founder, CEO, and member of the board of Nyctea Technologies.
6 people are employed at Nyctea Technologies.